World Journal of Urology

, Volume 33, Issue 6, pp 873–880 | Cite as

Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs

  • Paolo Capogrosso
  • Eugenio Ventimiglia
  • Rayan Matloob
  • Michele Colicchia
  • Alessandro Serino
  • Giulia Castagna
  • Maria Chiara Clementi
  • Giovanni La Croce
  • Umberto Capitanio
  • Giorgio Gandaglia
  • Rocco Damiano
  • Vincenzo Mirone
  • Francesco Montorsi
  • Andrea Salonia
Original Article

Abstract

Purpose

Assess knowledge and awareness concerning human papillomavirus (HPV) infection, HPV-associated diseases, and the existence of a specific vaccine among non-HPV-screened Caucasian-European adults after the market introduction of HPV vaccines.

Methods

A cohort of 934 consecutive patients seeking their first medical help for uroandrologic purposes anonymously completed a 17-item questionnaire related to HPV. Data were compared with those of an age-comparable cohort of nurses (controls; n = 172).

Results

Knowledge and awareness of HPV infection were reported in 564 (51 %) and 735 (66.5 %) participants, respectively. Overall, 51.3 % participants were informed that HPV is sexually transmitted, but most reported not being aware that HPV infection can be associated with anogenital warts (61.7 %), female genitalia (46.6 %), penile (58.5 %), and oropharyngeal cancer (79.7 %). Only 36.5 % of the participants were informed regarding the existence of a specific vaccine. HPV knowledge was retrieved through the media and/or the Internet, at school, doctors, and relatives or friends in 395 (35.7 %), 155 (14 %), 97 (8.8 %), and 88 (8.0 %) participants, respectively. Multivariable analyses showed that female gender [odds ratio (OR) 3.08; p < 0.001; 95 % confidence interval 2.18–4.35] and educational status [high school diploma versus primary–secondary (OR 1.61; p = 0.03; 1.04–2.51); university degree versus primary–secondary (OR 2.89; p < 0.001; 1.83–4.57)] were significantly associated with awareness of HPV.

Conclusions

Only approximately half of the participants reported knowing what HPV infection is, even after the approval and market introduction of the HPV vaccine. Awareness about the existence and availability of a HPV vaccine was even lower.

Keywords

Infertile couple Sexual dysfunction Awareness Human papillomavirus Anogenital warts Vaccine Cancer 

Supplementary material

345_2014_1379_MOESM1_ESM.doc (50 kb)
Supplementary material 1 (DOC 50 kb)

References

  1. 1.
    de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459PubMedGoogle Scholar
  2. 2.
    Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, Abrahamsen M, Salmeron J, Anic GM, Rollison DE, Smith D (2011) Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 377:932–940PubMedCentralPubMedGoogle Scholar
  3. 3.
    Vardas E, Giuliano AR, Goldstone S, Palefsky JM, Moreira ED Jr, Penny ME, Aranda C, Jessen H, Moi H, Ferris DG, Liaw KL, Marshall JB, Vuocolo S, Barr E, Haupt RM, Garner EI, Guris D (2011) External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis 203:58–65PubMedCentralPubMedGoogle Scholar
  4. 4.
    Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygård J, Nygård M (2007) The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 196:1447–1454PubMedGoogle Scholar
  5. 5.
    Palefsky JM, Rubin M (2009) The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin N Am 36:187–200Google Scholar
  6. 6.
    Kirrander P, Kolaric A, Helenius G, Windahl T, Andrén O, Stark JR, Lillsunde-Larsson G, Elgh F, Karlsson M (2011) Human papillomavirus prevalence, distribution and correlation to histopathological parameters in a large Swedish cohort of men with penile carcinoma. BJU Int 108:355–359PubMedGoogle Scholar
  7. 7.
    Van Dijk BA, Gatta G, Capocaccia R, Pierannunzio D, Strojan P, Licitra L, The RARECARE Working Group (2012) Rare cancers of the head and neck area in Europe. Eur J Cancer 48:783–796PubMedGoogle Scholar
  8. 8.
    Malloy KM, Ellender SM, Goldenberg D, Dolan RW (2013) A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4452 (Epub ahead of print)
  9. 9.
    Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, Markowitz LE, Smith D, Harris RB (2007) The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 196:1146–1152PubMedCentralPubMedGoogle Scholar
  10. 10.
    Garolla A, Lenzi A, Palù G, Pizzol D, Bertoldo A, De Toni L, Foresta C (2012) Human papillomavirus sperm infection and assisted reproduction: a dangerous hazard with a possible safe solution. Hum Reprod 27:967–973PubMedGoogle Scholar
  11. 11.
    Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A (2009) Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial. Lancet 373:1949–1957PubMedGoogle Scholar
  12. 12.
    Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D (2011) Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 364:401–411PubMedCentralPubMedGoogle Scholar
  13. 13.
    Klug SJ, Hukelmann M, Blettner M (2008) Knowledge about infection with human papillomavirus: a systematic review. Prev Med 46:87–98PubMedGoogle Scholar
  14. 14.
    Nøhr B, Munk C, Tryggvadottir L, Sparén P, Tran TN, Nygård M, Skare GB, Dasbach E, Liaw KL, Kjaer SK (2008) Awareness of human papillomavirus in a cohort of nearly 70,000 women from four Nordic countries. Acta Obstet Gynecol Scand 87:1048–1054PubMedGoogle Scholar
  15. 15.
    Nielsen A, Munk C, Liaw KL, Kjaer SK (2009) Awareness of human papillomavirus in 23,000 Danish men from the general male population. Eur J Cancer Prev 18:236–239PubMedGoogle Scholar
  16. 16.
    Schmeink CE, Gosens KC, Melchers WJ, Massuger LF, Bekkers RL (2011) Young adults awareness of HPV and vaccine acceptance after introduction of the HPV vaccine in the Dutch national vaccination program. Eur J Gynaecol Oncol 32:481–486PubMedGoogle Scholar
  17. 17.
    Bowyer HL, Marlow LA, Hibbitts S, Pollock KG, Waller J (2013) Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine 31:1051–1056CrossRefPubMedGoogle Scholar
  18. 18.
    Williams WW, Lu PJ, Saraiya M, Yankey D, Dorell C, Rodriguez JL, Kepka D, Markowitz LE (2013) Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine 1:2937–2946CrossRefGoogle Scholar
  19. 19.
    Samkange-Zeeb FN, Spallek L, Zeeb H (2011) Awareness and knowledge of sexually transmitted diseases (STDs) among school-going adolescents in Europe: a systematic review of published literature. BMC Public Health 11:727CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Hawkers N (2011) HIV epidemic in Europe is not under control, WHO says. BMJ 343:d7848CrossRefGoogle Scholar
  21. 21.
    Tsui J, Rodriguez HP, Gee GC, Escobedo LA, Kominski GF, Bastani R (2013) Are HPV vaccination services accessible to high-risk communities? A spatial analysis of HPV-associated cancer and Chlamydia rates and safety-net clinics. Cancer Causes Control 24:2089–2098PubMedGoogle Scholar
  22. 22.
    Hammond P (2011) Warts and all at last: HPV vaccination. BMJ 343:d7779CrossRefPubMedGoogle Scholar
  23. 23.
    Kuehn BM (2011) Patients go online seeking support, practical advice on health conditions. JAMA 305:1644–1645CrossRefPubMedGoogle Scholar
  24. 24.
    Madden K, Nan X, Briones R, Waks L (2012) Sorting through search results: a content analysis of HPV vaccine information online. Vaccine 30:3741–3746CrossRefPubMedGoogle Scholar
  25. 25.
    Lacey CJ (2005) Therapy for genital human papillomavirus-related disease. J Clin Virol 32(Suppl 1):S82–S90PubMedGoogle Scholar
  26. 26.
    Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, Negoita S, Villalon-Gomez JM (2008) Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer 113(10 Suppl):2883–2891CrossRefPubMedCentralPubMedGoogle Scholar
  27. 27.
    Castle PE, Rodríguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon D, Schiffman M, Proyecto Epidemiológico Guanacaste (PEG) Group (2009) Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 339:b2569CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, Malila N, Nieminen P (2010) Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 340:c1804CrossRefPubMedCentralPubMedGoogle Scholar
  29. 29.
    Blödt S, Holmberg C, Müller-Nordhorn J, Rieckmann N (2012) Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18–25 year old male and female vocational school students in Berlin, Germany. Eur J Public Health 22:808–813PubMedGoogle Scholar
  30. 30.
    Abalos AT, Harris RB, Nyitray AG, Mitchell A, Thompson PA, Giuliano AR, Garcia F (2012) Human papillomavirus type distribution among heterosexual couples. J Low Genit Tract Dis 16:10–15PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Paolo Capogrosso
    • 1
    • 2
  • Eugenio Ventimiglia
    • 2
  • Rayan Matloob
    • 2
  • Michele Colicchia
    • 2
  • Alessandro Serino
    • 1
    • 2
  • Giulia Castagna
    • 1
    • 2
  • Maria Chiara Clementi
    • 2
  • Giovanni La Croce
    • 1
    • 2
  • Umberto Capitanio
    • 2
  • Giorgio Gandaglia
    • 1
    • 2
  • Rocco Damiano
    • 3
  • Vincenzo Mirone
    • 4
  • Francesco Montorsi
    • 1
    • 2
  • Andrea Salonia
    • 2
    • 3
  1. 1.Università Vita-Salute San RaffaeleMilanItaly
  2. 2.Division of Oncology/Unit of Urology, URI-Urological Research InstituteIRCCS Ospedale San RaffaeleMilanItaly
  3. 3.Research Doctorate Program in UrologyMagna Graecia UniversityCatanzaroItaly
  4. 4.Department of Neurosciences, Reproductive Science and OdontostomatologyFederico II UniversityNaplesItaly

Personalised recommendations